Sanofi Pasteur, the vaccines division of Sanofi, has confirmed that it does have stock of Hepatitis A and Hepatitis A/Typhoid combination vaccines available in Australia
The announcement follows recent media coverage of possible impending shortages of Hepatitis A and B vaccines.
Sanofi Pasteur’s Avaxim vaccine is indicated for adults and children two years and above to help prevent Hepatitis A infection. Vivaxim is indicated for people aged 16 years and older to help prevent Hepatitis A and typhoid fever, also usually transmitted in unclean food or drink, in those who are at risk of these diseases.
Russell Jacobson, General Manager Sanofi Pasteur Australia, says both Avaxim and Vivaxim are available for Australians requiring vaccination.
“We would like to reassure healthcare professionals and patients seeking vaccinations for Hepatitis A, that vaccines are available,” he says.
“As always, people who are travelling overseas should visit their doctor before they travel.”
Meanwhile, GSK says it anticipates an intermittent stock out for Twinrix Adult (combined hepatitis A and B vaccine) in July 2017. Twinrix Junior remains available, it says.
GSK also advises that it is currently experiencing an on-going supply constraint of Engerix-B Adult dose (hepatitis B surface antigen recombinant (yeast) vaccine) in Australia: production is now back to normal however, it will take time to re-build capacity.
“At this stage we are unable to confirm a re-supply date.”